The week’s biotech discoveries included eight mutations that contribute to cardiomyopathy and an enzyme that promotes basal-like breast cancer.

University of Wisconsin researchers have found an enzyme that acts as a key regulator of p53, which they believe may inspire cancer treatments ideas.

Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA. It just added Cas14 to its arsenal.

Based on phase 2 data, a Georgetown University team showed that Tasigna reduces toxic protein clumps and restores dopamine metabolism in Parkinson's.

British researchers discovered that blocking the protein MAP4K4, which is activated by stress signals, can reduce muscle damage from a heart attack.

A University of Chicago-led team found that a porphyria drug could work with the popular diabetes treatment metformin in triple-negative breast cancer.

University of Tennessee scientists have designed a CD19-targeting CAR-T for lupus and have shown encouraging results in a mouse study.

The week’s biotech news included a novel method for halting the spread of malaria and new insight into how HIV weathers an immune attack.